Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets.
Gest C, Mirshahi P, Li H, Pritchard LL, Joimel U, Blot E, Chidiac J, Poletto B, Vannier JP, Varin R, Mirshahi M, Cazin L, Pujade-Lauraine E, Soria J, Soria C. Gest C, et al. Among authors: blot e. Cancer Lett. 2012 Apr 28;317(2):207-17. doi: 10.1016/j.canlet.2011.11.026. Epub 2011 Nov 25. Cancer Lett. 2012. PMID: 22120672
Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECT.
Guigay J, Chamorey E, Lefebvre G, Rotarski M, Wagner JP, Blot E, Alfonsi M, Seronde A, Schulten J, Peyrade F, Le Tourneau C. Guigay J, et al. Among authors: blot e. Cancer Rep (Hoboken). 2022 Feb;5(2):e1467. doi: 10.1002/cnr2.1467. Epub 2021 Jun 22. Cancer Rep (Hoboken). 2022. PMID: 34156166 Free PMC article. Clinical Trial.
CXCR4 membrane expression in node-negative breast cancer.
Blot E, Laberge-Le Couteulx S, Jamali H, Cornic M, Guillemet C, Duval C, Hellot MF, Pille JY, Picquenot JM, Veyret C. Blot E, et al. Breast J. 2008 May-Jun;14(3):268-74. doi: 10.1111/j.1524-4741.2008.00573.x. Epub 2008 Mar 26. Breast J. 2008. PMID: 18373506
A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study.
Trédan O, Follana P, Moullet I, Cropet C, Trager-Maury S, Dauba J, Lavau-Denes S, Diéras V, Béal-Ardisson D, Gouttebel M, Orfeuvre H, Stefani L, Jouannaud C, Bürki F, Petit T, Guardiola E, Becuwe C, Blot E, Pujade-Lauraine E, Bachelot T. Trédan O, et al. Among authors: blot e. Ann Oncol. 2016 Jun;27(6):1020-1029. doi: 10.1093/annonc/mdw077. Epub 2016 Feb 24. Ann Oncol. 2016. PMID: 26916095 Free article. Clinical Trial.
58 results